Cargando…
Anaplastic Multiple Myeloma: Case Series and Literature Review
BACKGROUND: Anaplastic multiple myeloma (AMM) is a very rare but distinct subtype of multiple myeloma (MM) with an extremely poor prognosis. Due to its rarity, AMM lacks detailed descriptions and clear definitions. Moreover, there is no consensus on the treatment and evidence suggests that AMM respo...
Autores principales: | Wu, Jian, Chu, Emily, Chase, Cristiana Costa, Choi, Taewoong, Gasparetto, Cristina, Young, Ken, Kang, Yubin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8881005/ https://www.ncbi.nlm.nih.gov/pubmed/35224465 http://dx.doi.org/10.36502/2022/asjbccr.6255 |
Ejemplares similares
-
PIM Kinases in Multiple Myeloma
por: Wu, Jian, et al.
Publicado: (2021) -
SLAMF7 as a Promising Immunotherapeutic Target in Multiple Myeloma Treatments
por: Chu, Emily, et al.
Publicado: (2023) -
The combination of a sphingosine kinase 2 inhibitor (ABC294640) and a Bcl‐2 inhibitor (ABT‐199) displays synergistic anti‐myeloma effects in myeloma cells without a t(11;14) translocation
por: Sundaramoorthy, Pasupathi, et al.
Publicado: (2018) -
Anaplastic multiple myeloma with MYC rearrangement
por: Ichikawa, Satoshi, et al.
Publicado: (2021) -
Inhibition of thioredoxin activates mitophagy and overcomes adaptive bortezomib resistance in multiple myeloma
por: Zheng, Zhihong, et al.
Publicado: (2018)